Thursday, March 12, 2026

Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains on News

 

 

Medical Tech Stock Aethlon Medical, Inc. (NASDAQ: $AEMD) Gains on News

 

 


 

 


(Investorideas.com Newswire) Investorideas.com, a leading investment platform for retail investors reports breaking Medical Tech Stock news for  Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases.

 

The stock gained today on news ,currently trading at 1.7300+0.0794 (+4.81%), with a day’s high of $1.94 on volume of over 859,000 shares as of this report.

 

Aethlon Medical, Inc. (Nasdaq: AEMD) today announced that it is evaluating a range of strategic opportunities and has engaged Maxim Group LLC (“Maxim”) to act as the Company’s exclusive financial advisor in connection with this process.

 

The Company engaged Maxim following preliminary inbound interest regarding potential strategic opportunities.  Maxim will assist the Company in reviewing a range of potential transactions, including partnerships, mergers, acquisitions or other opportunities involving the Company.

 

Paid News Dissemination of behalf of AEMD

 

Read this news, featuring AEMD in full at https://www.investorideas.com/CO/AEMD/news/2026/03122-aethlon-aemd-maxim-strategic-opportunities.asp

 

James Frakes, Chief Executive Officer and Chief Financial Officer of Aethlon stated, “The Company continues to execute its development activities, having completed the second cohort of our Australian oncology trial.   Safety data from that cohort will be submitted to the independent Data Safety Monitoring Board for review.   At the same time, we are evaluating strategic alternatives with the assistance of Maxim as part of our ongoing efforts to assess opportunities available to the Company and its shareholders.”

 

The Company has not established a definitive timeline for this evaluation and can provide no assurance that any transaction will result from this process.  The Company will pursue only those opportunities that the Board believes are appropriate for the Company and its shareholders.

 

About Maxim Group LLC

Founded in 2002, Maxim Group is a leading full-service investment bank, securities and wealth management firm headquartered in Midtown Manhattan providing a comprehensive array of financial services including investment banking, global institutional sales, equity research, fixed income and derivative sales & trading, merchant capital, private wealth management, and prime brokerage services to a diverse range of corporate clients, institutional investors and high-net-worth individuals. Maxim Group is a registered broker-dealer with the U.S. Securities and Exchange Commission and the Municipal Securities Rulemaking Board (MSRB). To learn more about Maxim Group, visit www.maximgrp.com.

 

About Aethlon Medical, Inc.

Aethlon Medical, Inc. (Nasdaq: AEMD) is a clinical-stage medical device company headquartered in San Diego, California. Aethlon is advancing the Hemopurifier, to address unmet needs in oncology and infectious disease, using a novel platform designed to selectively remove circulation pathogenic targets from biologic fluids.

For more information, visit www.AethlonMedical.com and follow the Company on LinkedIn.

 

Full news

https://www.investorideas.com/CO/AEMD/news/2026/03121-aethlon-aemd-maxim-strategic-opportunities.asp

 

Aethlon Medical Inc. (Nasdaq:AEMD) is a featured biotech stock on Investorideas.com

 

More info on AEMD at Investorideas.com Visit: https://www.investorideas.com/CO/AEMD/

 

Get News Alerts on Aethlon Medical

 

Disclaimer/Disclosure: Aethlon Medical, Inc. (AEMD) is a paid featured medical tech stock on Investor ideas More disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. More disclosure: Contact management and IR of each company directly regarding specific questions.

 

About Investorideas.com – Where you find the best investing ideas

Investorideas.com is the go-to platform for big investing ideas. From breaking stock news to top-rated investing podcasts, we cover it all


Get more 
biotech and medical tech news, articles, podcasts and stock directories

  






Follow us on X @investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

 

 

 


No comments: